Graphene breakthrough offers hope against antibiotic-resistant infections

With strong bactericidal properties, graphene has the potential to become a game changer in the fight against antibiotic-resistant bacteria.

ARCH-allied AN Venture Partners raises $200M to build biotechs out of research from Japan

A new investment firm affiliated with ARCH Venture Partners has raised $200 million for its first fund as it seeks to back scientific research out

December 2, 2023

Psyence Group Announces Resignation of Board Member | Psychedelic Invest

Psyence Group Inc. (CSE:PSYG) (“Psyence” or the “Company”), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing announced

November 20, 2023

How Beneficiaries Really Feel About Medicare Advantage vs Traditional Medicare

Survey results released today contradict widely-held beliefs that Medicare Advantage enrollees are more satisfied because they receive better health services than those in traditional Medicare.

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.